Rhode Island · 2026 Regular Session · Bill
HB 7187: AN ACT RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 7187 is a bill introduced in the Rhode Island House on January 21, 2026. According to its official title, it concerns: AN ACT RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT. Primary sponsor: Casimiro, Kathleen Fogarty (Democratic), Lauren Carson (Democratic), Brandon Potter (Democratic), David Bennett (Democratic), Jay Edwards (Democratic). Most recent recorded action (February 3, 2026): 02/03/2026 Committee recommended measure be held for further study.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms.
Sponsors
Sponsors by party (alphabetical): Democratic 5
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Casimiro | Primary sponsor | Not applicable (committee) | — | — |
| Kathleen Fogarty | Primary sponsor | Democratic | House | 35 |
| Lauren Carson | Primary sponsor | Democratic | House | 75 |
| Brandon Potter | Primary sponsor | Democratic | House | 16 |
| David Bennett | Primary sponsor | Democratic | House | 20 |
| Jay Edwards | Primary sponsor | Democratic | House | 70 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- 02/03/2026 Committee recommended measure be held for further study
- 01/30/2026 Scheduled for hearing and/or consideration (02/03/2026)
- 01/21/2026 Introduced, referred to House Health & Human Services